CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 616,440 shares at $16.21 ($10.5M) on 2016-08-16, disclosed to the SEC on 2016-08-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.21 | 12,840 | $208K | 2.0% |
| 2 | $16.21 | 1,100 | $18K | 0.2% |
| 3 | $16.21 | 18,620 | $302K | 2.9% |
| 4 | $16.21 | 3,530 | $57K | 0.5% |
| 5 | $16.21 | 19,050 | $309K | 2.9% |
| 6 | $16.21 | 3,460 |
| $56K |
| 0.5% |
| 7 | $16.21 | 19,050 | $309K | 2.9% |
| 8 | $16.21 | 3,460 | $56K | 0.5% |
| 9 | $16.21 | 3,530 | $57K | 0.5% |
| 10 | $16.21 | 12,840 | $208K | 2.0% |
| 11 | $16.21 | 18,620 | $302K | 2.9% |
| 12 | $16.21 | 1,100 | $18K | 0.2% |
| 13 | $17.26 | 32,080 | $554K | 5.3% |
| 14 | $17.26 | 2,498 | $43K | 0.4% |
| 15 | $17.26 | 5,830 | $101K | 1.0% |
| 16 | $17.26 | 8,820 | $152K | 1.4% |
| 17 | $17.26 | 46,510 | $803K | 7.6% |
| 18 | $17.26 | 48,320 | $834K | 7.9% |
| 19 | $17.26 | 2,498 | $43K | 0.4% |
| 20 | $17.26 | 32,080 | $554K | 5.3% |
| 21 | $17.26 | 46,510 | $803K | 7.6% |
| 22 | $17.26 | 48,320 | $834K | 7.9% |
| 23 | $17.26 | 5,830 | $101K | 1.0% |
| 24 | $17.26 | 8,820 | $152K | 1.4% |
| 25 | $17.32 | 1,822 | $32K | 0.3% |
| 26 | $17.32 | 4,120 | $71K | 0.7% |
| 27 | $17.32 | 6,470 | $112K | 1.1% |
| 28 | $17.32 | 23,530 | $408K | 3.9% |
| 29 | $17.32 | 35,490 | $615K | 5.8% |
| 30 | $17.32 | 34,130 | $591K | 5.6% |
| 31 | $17.32 | 34,130 | $591K | 5.6% |
| 32 | $17.32 | 1,822 | $32K | 0.3% |
| 33 | $17.32 | 23,530 | $408K | 3.9% |
| 34 | $17.32 | 4,120 | $71K | 0.7% |
| 35 | $17.32 | 35,490 | $615K | 5.8% |
| 36 | $17.32 | 6,470 | $112K | 1.1% |
| Total | $17.08 avg | 616,440 | $10.5M | 100% |
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2018-12-12 | $13.2M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |